Delivery Order SPE2DB22D1055-SPE2DB24FSGF6

Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order, valued at $14,682.20, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,567,254,079 vials of the drug Cyclophosphamide, at 2 grams per vial. The contract has a firm-fixed price pricing type and a period of performance running through February 13, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,735.80 Firm Fixed Price Delivery Order is for the supply of 4567520460 - Cyclophosphamide 500 mg Vials, with a period of performance through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $163,436.68, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a wide range of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $5,142.20, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a potential value of up to $999,999,999.00. This single-award IDC serves as the primary vehicle...
This federal contract award, valued at $1,052.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $3,423.79, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $1,106.60, was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies. The contract award, valued at $3,763.73, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary...
This federal contract award, with a value of $1,379.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,605.12, was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which does not have a set-aside designation, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to...
  • SPE2DB22D1055
    Indefinite Delivery Contract
  • SPE2DB22D1055-SPE2DB24FSGF6
    Delivery Order

This federal contract award, valued at $3,735.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564628874 CYCLOPHOSPHAMIDE 500 MG VIALS, a critical pharmaceutical product.

Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the Department of Defense's military treatment programs and facilities worldwide.

The contract award does not have a set-aside designation, indicating it was issued on a full and open competition basis. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain network have enabled the company to secure numerous federal contracts to supply critical medical products to various government agencies, including the Department of Justice Federal Bureau of Investigation.

Generated 8/15/24, 9:47 AM